The top 5 OncLive TV videos of the week cover insights in ovarian cancer, breast cancer, head and neck cancer, pancreatic cancer, and follicular lymphoma.
|Podcasts|September 25, 2019
Perusing Progress Made in Ovarian Cancer Treatment Paradigm in Pasadena
Author(s)Onclive Team
We traveled to Pasadena, California, for a State of the Science Summit™ on Ovarian Cancer, which featured insights from City of Hope faculty.
Advertisement
We recently traveled to Pasadena, California, for a State of the Science Summit™ on Ovarian Cancer. At the meeting, faculty from City of Hope discussed the necessity of genetic testing as well as the latest data regarding the use of PARP inhibitors, immunotherapy, chemotherapy, and surgical debulking while explaining how these data can be interpreted in clinical practice.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
2
Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC
3
Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC
4
Etentamig Meets PFS, ORR Primary End Points in Triple-Class Exposed R/R Myeloma
5